BioUtah News
-
BioUtah Mourns Loss of Soft Cell Founder and CEO, John “Brent” Hunt
BioUtah and Utah’s life sciences community mourns the death of one our own, John “Brent” Hunt, age 59. …
-
Utah’s Control Medical Technology Gets FDA Clearance for New Mechanical Thrombectomy Platform
Control Medical Technology announced on May 7 that the FDA cleared the company’s Control 7 – 11F Mechanical…
-
IDbyDNA Participates in NIH National COVID-19 Genomics Consortium
The CDC is leading the national SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance initiative (SPHERES)…
-
Silver lining: opportunities can arise from the corona crisis
Author: Anja Petschauer Co-authors: Anna Derschang, Melitta Gilllespie gwSaar has been a member of BioUtah and a trusted partner…
-
BioUtah’s Newest Associate Member: Greg Gunn, Colliers International
BioUtah’s newest Associate Member is Greg Gunn at Colliers International. With over 35 years of experience in commercial…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
